Glibenclamide (OER formulation)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Glibenclamide (OER formulation), covering 2025-10-28 to 2025-10-28. Get the full timeline:
Most recent: Clinical Trial Update: OER Glibenclamide for Neuropathic Pain in Multiple Sclerosis [Phase 1]